The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Mechanism of action of nalidixic acid: Purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme
Open accessAbstract
A target protein for nalidixic and oxolinic acids in Escherichia coli , the nalA gene product (Pnal), was purified to homogeneity as judged by gel electrophoresis, using an in vitro complementation assay. It is a dimer of identical 110,000-dalton subunits. A polypeptide of this molecular weight is uniquely induced by a λ nalA transducing phage, thereby showing that the purified Pnal is a product of the nalA gene. Nalidixic and oxolinic acids inhibit DNA gyrase activity and induce formation of a relaxation complex analogue. Treatment of the complex with sodium dodecyl sulfate causes a doublestrand break in the DNA substrate and the resulting linear molecule seems covalently bound to protein. Complex formation, unlike the introduction of supertwists, does not require ATP or relaxed circular DNA and is insensitive to novobiocin. DNA gyrase from a strain with a nalA mutation conferring drug resistance ( nalA r ) is 1/100 as sensitive to oxolinic and nalidixic acids with respect to inhibition of supertwisting and induction of the pre-linearization complex. Addition of Pnal restores drug sensitivity and stimulates DNA gyrase activity. DNA gyrase preparations and Pnal catalyze a third reaction sensitive to nalidixic and oxolinic acids, the ATP-independent relaxation of supertwister DNA. Relaxation by gyrase from nalA r cells is drug resistant. The nicking-closing activity is distinct from E. coli ω protein in several properties, including the ability to relax positively supertwisted DNA. We postulate that the nalA gene product occurs in two molecular forms, as Pnal and as a gyrase component. Both forms catalyze nicking-closing, and inhibition of this activity by nalidixic and oxolinic acids may account for the inhibition of DNA synthesis by these drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Siegel, L. M., & Monty, K. J. (1966) · Biochimica et Biophysica Acta (BBA) - Biophysics including Photosynthesis · doi:10.1016/0926-6585(66)90333-5 · Cited by 2,226
DNA gyrase: an enzyme that introduces superhelical turns into DNA.
Gellert, M., Mizuuchi, K., O'Dea, M. H., & Nash, H. A. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.11.3872 · Cited by 1,204
Interaction between DNA and an Escherichia coli protein ω
Wang, J. C. (1971) · Journal of Molecular Biology · doi:10.1016/0022-2836(71)90334-2 · Cited by 786
Processing of Adenovirus 2-Induced Proteins
Anderson, C. W., Baum, P. R., & Gesteland, R. F. (1973) · Journal of Virology · doi:10.1128/jvi.12.2.241-252.1973 · Cited by 755
Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase.
Gellert, M., O'Dea, M. H., Itoh, T., & Tomizawa, J. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.12.4474 · Cited by 727
Conformational fluctuations of DNA helix.
Depew, D. E., & Wang, J. C. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.11.4275 · Cited by 558
Prophage lambda at unusual chromosomal locations
島田, 和., Weisberg, R. A., & Gottesman, M. E. (1972) · Journal of Molecular Biology · doi:10.1016/0022-2836(72)90443-3 · Cited by 422
Champoux, J. J., & Dulbecco, R. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.1.143 · Cited by 346
Cited by
How antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
Biochemistry of homologous recombination in Escherichia coli
Kowalczykowski, S. C., Dixon, D. A., Eggleston, A. K., Lauder, S. D., & Rehrauer, W. M. (1994) · Microbiological Reviews · doi:10.1128/mr.58.3.401-465.1994 · Cited by 1,250
Linkage map of Escherichia coli K-12, edition 6
Bachmann, B., & Low, K. B. (1980) · Microbiological Reviews · doi:10.1128/mmbr.44.1.1-56.1980 · Cited by 938
Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity
Gellert, M., Mizuuchi, K., O'Dea, M. H., Itoh, T., & Tomizawa, J.-I. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4772 · Cited by 833
DNA Gyrase: Structure and Function
Reece, R. J., & Maxwell, A. (1991) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239109114072 · Cited by 728
Ruiz, J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg222 · Cited by 711
DNA Gyrase and the Supercoiling of DNA
Cozzarelli, N. R. (1980) · Science · doi:10.1126/science.6243420 · Cited by 711
Self-citationExploiting bacterial DNA gyrase as a drug target: current state and perspectives
Collin, F., Karkare, S., & Maxwell, A. (2011) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3557-z · Cited by 606
Quinolones: from antibiotics to autoinducers
Heeb, S., Fletcher, M. P., Chhabra, S. R., Diggle, S. P., Williams, P., & Cámara, M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2010.00247.x · Cited by 595
Quinolone-Mediated Bacterial Death
Drlica, K., Malik, M., Kerns, R. J., & Zhao, X. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01617-06 · Cited by 570
Cell killing by the F plasmid CcdB protein involves poisoning of DNA-topoisomerase II complexes
Bernard, P., & Couturier, M. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90629-x · Cited by 510
Mechanisms of fluoroquinolone resistance
Hooper, D. C. (1999) · Drug Resistance Updates · doi:10.1054/drup.1998.0068 · Cited by 488
Topoisomerases as anticancer targets
Delgado, J. L., Hsieh, C.-M., Chan, N.-L., & Hiasa, H. (2018) · Biochemical Journal · doi:10.1042/bcj20160583 · Cited by 481
Regulation of the genes for E. coli DNA gyrase: Homeostatic control of DNA supercoiling
Menzel, R., & Gellert, M. (1983) · Cell · doi:10.1016/0092-8674(83)90140-x · Cited by 466
Escherichia coli DNA topoisomerase I mutants have compensatory mutations in DNA gyrase genes
Dinardo, S., Voelkel, K. A., Sternglanz, R., Reynolds, A. E., & Wright, A. (1982) · Cell · doi:10.1016/0092-8674(82)90403-2 · Cited by 446
The Quinolones: Past, Present, and Future
Andriole, V. T. (2005) · Clinical Infectious Diseases · doi:10.1086/428051 · Cited by 428
Shen, L. L., Mitscher, L. A., Sharma, P. N., O'Donnell, T. J., Chu, D. W. T., Cooper, C. S., Rosen, T., & Pernet, A. G. (1989) · Biochemistry · doi:10.1021/bi00435a039 · Cited by 413
Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance
Bush, N. G., Diez-Santos, I., Abbott, L. R., & Maxwell, A. (2020) · Molecules · doi:10.3390/molecules25235662 · Cited by 413
Processing of plasmid DNA during bacterial conjugation
Willetts, N. S., & Wilkins, B. M. (1984) · Microbiological Reviews · doi:10.1128/mmbr.48.1.24-41.1984 · Cited by 394
Levine, C., Hiasa, H., & Marians, K. J. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00126-2 · Cited by 391
Topoisomerase IV is a target of quinolones in Escherichia coli.
Khodursky, A. B., Zechiedrich, E. L., & Cozzarelli, N. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11801 · Cited by 378
Self-citationEnzymatic replication of the origin of the Escherichia coli chromosome.
Fuller, R. S., Kaguni, J. M., & Kornberg, A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.12.7370 · Cited by 377
Cohen, S. P., McMurry, L. M., Hooper, D. C., Wolfson, J. S., & Levy, S. B. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1318 · Cited by 376
Quinolones: Action and Resistance Updated
Drlica, K., Hiasa, H., Kerns, R., Malik, M., Mustaev, A., & Zhao, X. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789630947 · Cited by 376
Thieringer, H. A., Jones, P. G., & Inouye, M. (1998) · BioEssays · doi:10.1002/(sici)1521-1878(199801)20:1<49::aid-bies8>3.0.co;2-n · Cited by 363
A homogeneous type II DNA topoisomerase from HeLa cell nuclei.
Miller, K. G., Liu, L. F., & Englund, P. T. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52552-2 · Cited by 356
Multidrug-Resistant Mycobacterium tuberculosis: Molecular Perspectives
Rattan, A., Kalia, A., & Ahmad, N. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0402.980207 · Cited by 355
Camptothecin and Taxol: Historic Achievements in Natural Products Research
Oberlies, N. H., & Kroll, D. J. (2004) · Journal of Natural Products · doi:10.1021/np030498t · Cited by 353
Kreuzer, K. N., & Cozzarelli, N. R. (1979) · Journal of Bacteriology · doi:10.1128/jb.140.2.424-435.1979 · Cited by 337
Self-citationA Sign Inversion Mechanism for Enzymatic Supercoiling of DNA
Brown, P. O., & Cozzarelli, N. R. (1979) · Science · doi:10.1126/science.227059 · Cited by 332
Self-citationGenomic transcriptional response to loss of chromosomal supercoiling in Escherichia coli
Peter, B. J., Arsuaga, J., Breier, A. M., Khodursky, A. B., Brown, P. O., & Cozzarelli, N. R. (2004) · Genome Biology · doi:10.1186/gb-2004-5-11-r87 · Cited by 323
Self-citationDNA Topoisomerases: Enzymes That Control DNA Conformation
Vosberg, H.-P. (1985) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-70227-3_2 · Cited by 321
Multi-targeting by monotherapeutic antibacterials
Silver, L. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2202 · Cited by 311
DNA transport by a type II DNA topoisomerase: Evidence in favor of a two-gate mechanism
Roca, J., & Wang, J. C. (1994) · Cell · doi:10.1016/0092-8674(94)90222-4 · Cited by 288
ATP-dependent DNA topoisomerase from D. melanogaster reversibly catenates duplex DNA rings
Hsieh, T.-S., & Brutlag, D. (1980) · Cell · doi:10.1016/0092-8674(80)90119-1 · Cited by 286
Double strand DNA cleavage by type II DNA topoisomerase from Drosophila melanogaster.
Sander, M., & Hsieh, T. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82081-x · Cited by 285
Sternglanz, R., DiNardo, S., Voelkel, K. A., Nishimura, Y., Hirota, Y., Becherer, K., Zumstein, L., & Wang, J. C. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.5.2747 · Cited by 285
Structure-activity relationships of the fluoroquinolones
Chu, D. T., & Fernandes, P. B. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.2.131 · Cited by 284
Wang, Y., Huang, W. M., & Taylor, D. E. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.457 · Cited by 280
Interactions of bacteriophage and host macromolecules in the growth of bacteriophage lambda
Friedman, D. I., Olson, E. R., Georgopoulos, C. P., Tilly, K., Herskowitz, I., & Banuett, F. (1984) · Microbiological Reviews · doi:10.1128/mmbr.48.4.299-325.1984 · Cited by 279
The interaction between coumarin drugs and DNA gyrase
Maxwell, A. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01728.x · Cited by 264
Liu, L. F., Liu, C.-C., & Alberts, B. M. (1979) · Nature · doi:10.1038/281456a0 · Cited by 264
Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli
Yamagishi, J.-I., Yoshida, H., Yamayoshi, M., & Nakamura, S. (1986) · Molecular and General Genetics MGG · doi:10.1007/bf00331012 · Cited by 263
Peng, H., & Marians, K. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80551-1 · Cited by 261
Interfacial inhibitors: targeting macromolecular complexes
Pommier, Y., & Marchand, C. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3404 · Cited by 259
Mechanistic Aspects of DNA Topoisomerases
Maxwell, A., & Gellert, M. (1986) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60526-4 · Cited by 258
Purification of subunits of Escherichia coli DNA gyrase and reconstitution of enzymatic activity
Higgins, N. P., Peebles, C. L., Sugino, A., & Cozzarelli, N. R. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.4.1773 · Cited by 257
Self-citationType II topoisomerases--inhibitors, repair mechanisms and mutations
Heisig, P. (2009) · Mutagenesis · doi:10.1093/mutage/gep035 · Cited by 63
Metadata
- Authors
- Sugino, A., Peebles, C. L., Kreuzer, K. N., & Cozzarelli, N. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1977-11
- Volume
- 74
- Issue
- 11
- Pages
- 4767-4771
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2027611515
- Cited by
- 784
- References
- 12
- FWCI
- 27.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.